|
Richard J. Meelia is chief executive officer of Tyco Healthcare, a business segment of Tyco International. He has directed Tyco’s Healthcare acquisition, integration and product development efforts growing the segment from a stand-alone business to the diverse nearly $10 billion business it is today. Meelia joined Kendall Healthcare Products, the foundation of the Tyco Healthcare business segment, as group president in 1991. In 1995, he became president of the newly-created Tyco Healthcare segment. Before joining Kendall/Tyco Healthcare, Meelia was the president of Infusaid, Inc., a manufacturer and marketer of implantable infusion pumps and ports and division of Pfizer Hospital Products Group. Prior to that, he held various sales and marketing positions with the Pharmaseal and McGaw divisions of the American Hospital Supply Corporation. Meelia received his bachelor’s degree from St. Anselm College and a holds a master’s degree in business administration from Boston College. He also serves on the board of directors of Aspect Medical Systems; Chernobyl Children Project, Inc. and St. Anselm College and is chairman of the board of directors for Employ+Ability, Inc., a career empowerment network for people with disabilities. About Tyco Healthcare Tyco Healthcare manufactures, distributes and services an extensive product line including disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. With industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, United States Surgical and Valleylab, Tyco Healthcare products are found in virtually every healthcare setting.
| 